The Latin America, Middle East and Africa Hearing Loss Disease Treatment Market would witness market growth of 7.9% CAGR during the forecast period (2022-2028).
Unexpected hearing loss occurrence, aging population, viral ear infections, head trauma, genetic syndrome, aircraft sounds at the workplace are some common source that induces hearing loss treatment. The technological development in surgical innovations & procedures in the efficiency of hearing loss devices is accelerating the multi-dollar development in the market.
Common awareness about hearing loss treatment among hearing healthcare professionals & the public is expected to boost growth opportunities. Audiometry examinations can inspect human hearing more precisely and thoroughly. An audiologist examines the patient’s hearing capability throughout these examinations by using earphones. A sequence of different volumes & noises is sent to each ear one at a time. This aids in determining the degree to which hearing starts to decline.
It is anticipated that the UAE medical device business will witness significant growth due to the accelerating economy. The government will support the involvement of the private sector as the price of healthcare rises. The main drivers would be evolving epidemiology, population rise, infrastructure improvements in the healthcare sector, the medical tourism business, digital transformation, the expansion of health insurance, and new technologies. Considering all these factors, the market players in the hearing loss treatment market get investment opportunities in the LAMEA region.
The Brazil market dominated the LAMEA Hearing Loss Disease Treatment Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $298 Million by 2028.The Argentina market is exhibiting a CAGR of 8.5% during (2022 - 2028). Additionally, The UAE market would showcase a CAGR of 7.6% during (2022 - 2028).
Based on Disease Type, the market is segmented into Sensorineural, Conductive and Mixed. Based on Product, the market is segmented into Devices and Drugs. Based on End-user, the market is segmented into Otology Clinics, Hospitals and Ambulatory Clinics. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Novartis AG, Astellas Pharma, Inc, WS Audiology A/S, Otonomy, Inc, Sensorion, Frequency Therapeutics, Inc, Acousia Therapeutics GmbH, Pipeline Therapeutics, Inc, Audina Hearing Instruments, Inc, and Audifon GmbH & CO. KG.
Unexpected hearing loss occurrence, aging population, viral ear infections, head trauma, genetic syndrome, aircraft sounds at the workplace are some common source that induces hearing loss treatment. The technological development in surgical innovations & procedures in the efficiency of hearing loss devices is accelerating the multi-dollar development in the market.
Common awareness about hearing loss treatment among hearing healthcare professionals & the public is expected to boost growth opportunities. Audiometry examinations can inspect human hearing more precisely and thoroughly. An audiologist examines the patient’s hearing capability throughout these examinations by using earphones. A sequence of different volumes & noises is sent to each ear one at a time. This aids in determining the degree to which hearing starts to decline.
It is anticipated that the UAE medical device business will witness significant growth due to the accelerating economy. The government will support the involvement of the private sector as the price of healthcare rises. The main drivers would be evolving epidemiology, population rise, infrastructure improvements in the healthcare sector, the medical tourism business, digital transformation, the expansion of health insurance, and new technologies. Considering all these factors, the market players in the hearing loss treatment market get investment opportunities in the LAMEA region.
The Brazil market dominated the LAMEA Hearing Loss Disease Treatment Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $298 Million by 2028.The Argentina market is exhibiting a CAGR of 8.5% during (2022 - 2028). Additionally, The UAE market would showcase a CAGR of 7.6% during (2022 - 2028).
Based on Disease Type, the market is segmented into Sensorineural, Conductive and Mixed. Based on Product, the market is segmented into Devices and Drugs. Based on End-user, the market is segmented into Otology Clinics, Hospitals and Ambulatory Clinics. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Novartis AG, Astellas Pharma, Inc, WS Audiology A/S, Otonomy, Inc, Sensorion, Frequency Therapeutics, Inc, Acousia Therapeutics GmbH, Pipeline Therapeutics, Inc, Audina Hearing Instruments, Inc, and Audifon GmbH & CO. KG.
Scope of the Study
Market Segments Covered in the Report:
By Disease Type
- Sensorineural
- Conductive
- Mixed
By Product
- Devices
- Drugs
By End-user
- Otology Clinics
- Hospitals
- Ambulatory Clinics
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Novartis AG
- Astellas Pharma, Inc
- WS Audiology A/S
- Otonomy, Inc
- Sensorion
- Frequency Therapeutics, Inc
- Acousia Therapeutics GmbH
- Pipeline Therapeutics, Inc
- Audina Hearing Instruments, Inc
- Audifon GmbH & CO. KG
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Hearing Loss Disease Treatment Market, by Disease Type
1.4.2 LAMEA Hearing Loss Disease Treatment Market, by Product
1.4.3 LAMEA Hearing Loss Disease Treatment Market, by End-user
1.4.4 LAMEA Hearing Loss Disease Treatment Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Hearing Loss Disease Treatment Market
Chapter 4. LAMEA Hearing Loss Disease Treatment Market by Disease Type
4.1 LAMEA Sensorineural Market by Country
4.2 LAMEA Conductive Market by Country
4.3 LAMEA Mixed Market by Country
Chapter 5. LAMEA Hearing Loss Disease Treatment Market by Product
5.1 LAMEA Devices Market by Country
5.2 LAMEA Drugs Market by Country
Chapter 6. LAMEA Hearing Loss Disease Treatment Market by End-user
6.1 LAMEA Otology Clinics Market by Country
6.2 LAMEA Hospitals Market by Country
6.3 LAMEA Ambulatory Clinics Market by Country
Chapter 7. LAMEA Hearing Loss Disease Treatment Market by Country
7.1 Brazil Hearing Loss Disease Treatment Market
7.1.1 Brazil Hearing Loss Disease Treatment Market by Disease Type
7.1.2 Brazil Hearing Loss Disease Treatment Market by Product
7.1.3 Brazil Hearing Loss Disease Treatment Market by End-user
7.2 Argentina Hearing Loss Disease Treatment Market
7.2.1 Argentina Hearing Loss Disease Treatment Market by Disease Type
7.2.2 Argentina Hearing Loss Disease Treatment Market by Product
7.2.3 Argentina Hearing Loss Disease Treatment Market by End-user
7.3 UAE Hearing Loss Disease Treatment Market
7.3.1 UAE Hearing Loss Disease Treatment Market by Disease Type
7.3.2 UAE Hearing Loss Disease Treatment Market by Product
7.3.3 UAE Hearing Loss Disease Treatment Market by End-user
7.4 Saudi Arabia Hearing Loss Disease Treatment Market
7.4.1 Saudi Arabia Hearing Loss Disease Treatment Market by Disease Type
7.4.2 Saudi Arabia Hearing Loss Disease Treatment Market by Product
7.4.3 Saudi Arabia Hearing Loss Disease Treatment Market by End-user
7.5 South Africa Hearing Loss Disease Treatment Market
7.5.1 South Africa Hearing Loss Disease Treatment Market by Disease Type
7.5.2 South Africa Hearing Loss Disease Treatment Market by Product
7.5.3 South Africa Hearing Loss Disease Treatment Market by End-user
7.6 Nigeria Hearing Loss Disease Treatment Market
7.6.1 Nigeria Hearing Loss Disease Treatment Market by Disease Type
7.6.2 Nigeria Hearing Loss Disease Treatment Market by Product
7.6.3 Nigeria Hearing Loss Disease Treatment Market by End-user
7.7 Rest of LAMEA Hearing Loss Disease Treatment Market
7.7.1 Rest of LAMEA Hearing Loss Disease Treatment Market by Disease Type
7.7.2 Rest of LAMEA Hearing Loss Disease Treatment Market by Product
7.7.3 Rest of LAMEA Hearing Loss Disease Treatment Market by End-user
Chapter 8. Company Profiles
8.1 Novartis AG
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.2 Astellas Pharma, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.3 WS Audiology A/S
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.4 Otonomy, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Research & Development Expenses
8.4.4 Recent strategies and developments:
8.4.4.1 Partnerships, Collaborations, and Agreements:
8.5 Sensorion
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Research & Development Expenses
8.5.4 Recent strategies and developments:
8.5.4.1 Partnerships, Collaborations, and Agreements:
8.6 Frequency Therapeutics, Inc
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Research & Development Expenses
8.6.4 Recent strategies and developments:
8.6.4.1 Partnerships, Collaborations, and Agreements:
8.7 Acousia Therapeutics GmbH
8.7.1 Company Overview
8.8 Pipeline Therapeutics, Inc
8.8.1 Company Overview
8.9 Audina Hearing Instruments, Inc.
8.9.1 Company Overview
8.10. Audifon GmbH & CO. KG
8.10.1 Company Overview
Companies Mentioned
- Novartis AG
- Astellas Pharma, Inc
- WS Audiology A/S
- Otonomy, Inc
- Sensorion
- Frequency Therapeutics, Inc
- Acousia Therapeutics GmbH
- Pipeline Therapeutics, Inc
- Audina Hearing Instruments, Inc
- Audifon GmbH & CO. KG
Methodology
LOADING...
